Description
Innovative Targeting Strategies in Breast Cancer Therapy is a comprehensive reference addressing the challenge of non-specific drug distribution in the body, along with severe toxicity and adverse effects, by offering insights into targeted breast cancer treatment. It further educates researchers on formulating and developing novel carriers with target-specific attributes (such as targeted liposomes, nanoparticles, micelles, and dendrimers), contributing to a more refined approach to breast cancer. This book's content is presented in 12 chapters. The first chapters introduces the reader to the different breast cancer therapies followed by indepth information on targeting . Recognizing the need for targeted drug delivery in breast cancer treatment, this book presents an encompassing compilation of advanced research and formulation strategies. By focusing on effectively targeting cancer cells, the book mitigates dose-related toxicity associated with cytotoxic drugs, providing a comprehensive resource for improved treatment approaches. Research in oncology, pharmacology, medical researchers, biomedical engineers and clinical professionals will find this an essential reference.- Delves into the intricacies of delivering drugs in cancer precisely to designated sites through molecular recognition- Provides in-depth coverage of existing market formulations, ongoing clinical trials, and intellectual property rights pertaining to targeted breast cancer therapies- Offers researchers up-to-date insights into breast cancer targeting strategies
Table of Contents
1. Chemotherapeutic drugs and its side effects, breast cancer biomarkers, detection, level of targeting and EPR effect2. Receptor-ligand based targeting approaches breast cancer3. Stimuli-based targeting breast cancer4. Advance strategies for targeting severe triple-negative breast cancer5. Targeted therapy for BRCA gene mutations breast cancer6. Androgen receptor targeted therapy for breast cancer7. Monoclonal antibodies-based breast cancer targeting8. Breast cancer stem cell targeting9. The Role of Hormone Receptors in Breast Cancer: New opportunities for Treatment and Prevention10. HER2-positive and HER2-negative Targeted Therapies11. Immunotherapy for breast cancer12. Current market formulation, therapy in clinical trails, and status of IPR for breast cancer
